- Home
- EDRY vs FORA Comparison
EDRY vs FORA Comparison
Compare EDRY & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDRY | FORA |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.3M | 66.2M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EDRY | FORA |
|---|---|---|
| Price | $18.59 | $2.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 30.3K | 14.3K |
| Earning Date | 02-19-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $20,153,263.00 |
| Revenue This Year | $27.85 | $51.82 |
| Revenue Next Year | $10.51 | $7.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.64 | $1.64 |
| 52 Week High | $23.98 | $2.71 |
Technical Indicators
Market Signals| Indicator | EDRY | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 52.65 | 37.16 |
| Support Level | $11.73 | $1.95 |
| Resistance Level | $23.98 | $2.12 |
| Average True Range (ATR) | 1.63 | 0.02 |
| MACD | -0.39 | -0.00 |
| Stochastic Oscillator | 31.92 | 14.29 |
Price Performance
Historical ComparisonAbout EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.